Amylyx Pharmaceuticals (AMLX) Earnings Date & Reports

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AMLX is expected to report earnings to fall 4.76% to -35 cents per share on August 06

Amylyx Pharmaceuticals AMLX Stock Earnings Reports

Q2'26

Est.

$-0.35

Q1'26

Missed

by $0.04

Q4'25

Beat

by $0.04

Q3'25

Beat

by $0.08

Q2'25

Est.

$-0.46

The last earnings report on May 07 showed earnings per share of -37 cents, missing the estimate of -33 cents. With 921.49K shares outstanding, the current market capitalization sits at 1.81B.

View a ticker or compare two or three

Compare

AMLX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AMLX